AN ASSOCIATION OF EXPERTS

Immunotherapy,
together.

C3I brings together physicians, researchers, pharmacists and other experts who work collaboratively to advance innovative immunotherapies in IMIDs.

110
members of the association
16
multidisciplinary
working groups
Discover the club Explore further
Artistic evocation of immune cells in turquoise and midnight blue tones
At the heart of immunity,
new questions.
COMPLEMENTARY PERSPECTIVES
ImmunologyTranslational researchClinical medicine
01 / THE CLUB

One shared focus.
Many perspectives.

The Club for innovative immunotherapies in IMIDs is an association of experts who bring their skills together.

Physicians, researchers and pharmacists collaborate across disciplines through 16 working groups.

Its ambition: to advance research, share knowledge and support the development of innovative immunotherapies in immune-mediated inflammatory diseases, or IMIDs.

Our scientific objectives
02 / OUR APPROACH

Bringing knowledge together.

Three perspectives on
immunotherapy innovation.

01
UNDERSTAND

Immunological
mechanisms

Connecting biological questions with clinical challenges to better frame therapeutic targets and strategies.

From mechanism to target
02
EVALUATE

Scientific
evidence

Assessing the quality of results, methodological limitations and the questions that remain open.

From data to interpretation
03
EXCHANGE

Clinical
perspectives

Bringing specialties together and identifying shared research questions.

From dialogue to new questions
03 / A CROSS-CUTTING FIELD

IMIDs,
beyond
disciplinary boundaries.

IMIDs

Immune-mediated inflammatory diseases

A cross-cutting approach helps identify shared features across diseases while respecting their specificities.

For C3I, this perspective creates a space for dialogue between fundamental research, translational research and clinical thinking.

A shared ambitionConnect disciplines.
Deepen the questions.